Basics Organon & Co.. IPO Date: May 14, 2021 Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $2.34B Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 1.64% Avg Daily Range (30 D): $0.17 | 1.65% Avg Daily Range (90 D): $0.19 | 1.93% Institutional Daily Volume Avg Daily Volume: 2.36M Avg Daily Volume (30 D): 2.88M Avg Daily Volume (90 D): 3.19M Trade Size Avg Trade Size (Sh.): 99 Avg Trade Size (Sh.) (30 D): 110 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 3,925 Avg Inst. Trade: $3.53M Avg Inst. Trade (30 D): $4.82M Avg Inst. Trade (90 D): $3.97M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.99M Avg Closing Trade (30 D): $6.59M Avg Closing Trade (90 D): $5.76M Avg Closing Volume: 398.48K     News Sep 15, 2025 @ 6:06 PM Women’s Health Collective Canada Launches V... Source: Daniel St. Germaine Sep 15, 2025 @ 6:06 PM L’Association canadienne pour l’é... Source: Association Canadienne Pour L'Équité En Santé Des Femmes (Acesf) Aug 14, 2025 @ 8:18 PM Daré Bioscience Posts Narrower Q2 Loss Source: Jesterai Jul 23, 2025 @ 5:00 PM Global Dysmenorrhea Treatment Market to Cross ~USD... Source: Delveinsight Jul 21, 2025 @ 8:00 PM OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman ... Source: Bronstein, Gewirtz & Grossman Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $2.71 $.56 $.34 Diluted EPS $2.68 $.56 $.33 Revenue $ 6.28B $ 1.59B $ 1.51B Gross Profit $ 3.53B $ 874M $ 841M Net Income / Loss $ 700M $ 145M $ 87M Operating Income / Loss $ 666M $ 229M $ 101M Cost of Revenue $ 2.75B $ 720M $ 672M Net Cash Flow $ -105M $ 52M $ -128M PE Ratio 3.38